CLChaogeng Lyu

Chaogeng Lyu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chaogeng Lyu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Chuanzhi Kang

    State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China

    2 shared publications
  • Lanping Guo

    State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herb, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, China

    2 shared publications
  • Sheng Wang

    State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China

    2 shared publications
  • Changzheng Liu

    State Key Laboratory for Quality Ensurance and Sustainable use of Dao‐di Herbs National Resource Center for Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing China

    1 shared publication
  • Chenglong Sun

    Key Laboratory for Applied Technology of Sophisticated Analytical Instruments of Shandong Province, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China

    1 shared publication
  • Chunxia Ma

    Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences)

    1 shared publication

Latest Publications

  • High‐resolution dual‐polarity molecular imaging platform unraveling spatial metabolic heterogeneity in multiple plant tissues

    by Guanhua Zhang, Chunxia Ma, Sheng Wang, Chuanzhi Kang, Chenglong Sun, Wei Liu, Chaogeng Lyu, Xiao Wang, Lanping Guo

    Exploring the metabolic characteristics of different plant organs and tissues at a spatial level can help us to better understand the functional mechanisms of biological tissues and cells. Mass spectrometry imaging (MSI) provides a reliable tool for this purpose. However, its application for high‐resolution metabolic mapping across various plant organs remains a significant challenge due to the intrinsic biological properties of plant samples and unfavorable analysis conditions. This study aimed to develop a novel MSI platform that can expand more diverse plant samples in spatial metabolomics research and enhance the detection efficiency of plant metabolites. The platform (AMG–LDI–MSI) based on an Au nanoparticles‐loaded MoS 2 and doped graphene oxide (Au@MoS 2 /GO) flexible film substrate combined with laser desorption/ionization (LDI)–MSI was established to enhance the detection and visualization of metabolites in various plant tissues. It has a non‐sectioning, matrix‐free, dual‐ion mode imaging strategy, enabling high‐throughput detection of metabolites and high‐resolution molecular imaging within a micrometer scale. The Au@MoS 2 /GO as a new substrate can offer high sensitivity and molecular coverage for diverse plant metabolites (10 classes) under the positive and negative ion modes. Moreover, the AMG–LDI–MSI platform overcomes the limitations of plant tissues (e.g., fragile leaf, water‐rich fruit, or lignified roots) for in situ imaging. We successfully applied the platform to map the metabolite spatial dynamics in different types of fresh tissues (rhizome, main root, branch root, fruit, leaf, and nodule) from medicinal plants, obtained the high‐quality mass spectral imaging data, and demonstrated the universality and applicability of the platform to multiple plant tissues. These results demonstrate the significant advantages of enhancing the detection of multiple tissue metabolites in plants and their high‐resolution imaging. It has overcome the limitations of previously reported MSI methods, suggesting that it could become a widely used tool for deciphering metabolic networks in plant biology.


  • A prenyltransferase participates in the biosynthesis of anthraquinones in Rubia cordifolia

    by Changzheng Liu, Ruishan Wang, Sheng Wang, Tong Chen, Chaogeng Lyu, Chuanzhi Kang, Xiufu Wan, Juan Guo, Qi Li, Luqi Huang, et al.

    Anthraquinones constitute the largest group of natural quinones, which are used as safe natural dyes and have many pharmaceutical applications. In plants, anthraquinones are biosynthesized through two main routes: the polyketide pathway and the shikimate pathway. The latter primarily forms alizarin-type anthraquinones, and the prenylation of 1,4-dihydroxy-2-naphthoic acid is the first pathway-specific step. However, the prenyltransferase responsible for this key step remains uncharacterized. In this study, the cell suspension culture of Madder (Rubia cordifolia), a plant rich in alizarin-type anthraquinones, was discovered to be capable of prenylating 1,4-dihydroxy-2-naphthoic acid to form 2-carboxyl-3-prenyl-1,4-naphthoquinone and 3-prenyl-1,4-naphthoquinone. Then, a candidate gene belonging to the UbiA superfamily, R. cordifolia dimethylallyltransferase 1 (RcDT1), was shown to account for the prenylation activity. Substrate specificity studies revealed that the recombinant RcDT1 recognized naphthoic acids primarily, followed by 4-hydroxyl benzoic acids. The prenylation activity was strongly inhibited by 1,2- and 1,4-dihydroxynaphthalene. RcDT1 RNA interference significantly reduced the anthraquinones content in R. cordifolia callus cultures, demonstrating that RcDT1 is required for alizarin-type anthraquinones biosynthesis. The plastid localization and root-specific expression further confirmed the participation of RcDT1 in anthraquinone biosynthesis. The phylogenetic analyses of RcDT1 and functional validation of its rubiaceous homologs indicated that DHNA-prenylation activity evolved convergently in Rubiaceae via recruitment from the ubiquinone biosynthetic pathway. Our results demonstrate that RcDT1 catalyzes the first pathway-specific step of alizarin-type anthraquinones biosynthesis in R. cordifolia. These findings will have profound implications for understanding the biosynthetic process of the anthraquinone ring derived from the shikimate pathway.